Login / Signup

Effect of tibolone on the survival of early stage cervical adenocarcinoma patients.

Seung-Ho LeeYoon-Jin ChoKyung-Joo ChoMee-Hyang KoSun-Young JungSeung-Joo ChonSo-Yi LimKwang Beom Lee
Published in: Obstetrics & gynecology science (2018)
Tibolone has no adverse effect on the survival of cervical AC patients and can be administered safely to this population. These findings may be helpful in improving the quality of life of cervical AC patients.
Keyphrases
  • end stage renal disease
  • early stage
  • ejection fraction
  • newly diagnosed
  • squamous cell carcinoma
  • prognostic factors
  • patient reported outcomes
  • electronic health record